CD8A and neoplasm: Finally, the successful profiling of the NP vaccine-induced polyfunctional human CD8+ T cells using single-cell proteomics may serve as predictive biomarkers for a more accurate evaluation of tumor vaccine efficacy in a pre-clinical setting.